| TheraSphere (yttrium 90 microspheres) / Boston Scientific |
NCT00039078: Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery |
|
|
| Withdrawn | 2 | 0 | US | yttrium Y 90 glass microspheres | Allan Tsung | Liver Cancer | 08/00 | 08/00 | | |
NCT00910572: Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma |
|
|
| Completed | 2 | 60 | Europe | Yttrium-90 microspheres (Therasphere MDS Nordion), Therasphere, produced by MDS Nordion, Ottawa, Canada | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Gastro Intestinal Surgery and Liver Transplantation, The Hepato-Oncology Group: Department of Surgery, Medicine and Radiology | Hepatocellular Carcinoma, Liver Cancer | 11/09 | 05/10 | | |
NCT01290536: Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases |
|
|
| Completed | 2 | 42 | NA | Selective internal radiation therapy to the liver using Yttrium-90 glass microspheres (TheraSphere) | Nicholas Fidelman, MD | Colorectal Neoplasms, Neuroendocrine Tumors, Cholangiocarcinoma, Melanoma, Breast Cancer | 10/13 | 10/13 | | |
NCT01177007: Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors |
|
|
| Completed | 2 | 50 | US | TheraSphere, Yttrium-90 glass Microspheres | Yale University | Liver Neoplasms | 08/14 | 08/14 | | |
NCT01581307: Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets |
|
|
| Completed | 2 | 9 | US | FOLFOX7 (Folinic acid, 5-Fluorouracil, and Oxaliplatin), Leucovorin, LV, FOL, OX, 5-Fluorouracil (5-FU), FOLFOX, ELOXATIN, TheraSpheres, radiotherapy, radioembolization | H. Lee Moffitt Cancer Center and Research Institute, BTG International Inc. | Liver Cancer, Pancreatic Cancer | 02/16 | 03/16 | | |
MispheC, NCT01912053: Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma |
|
|
| Completed | 2 | 41 | Europe | Therasphere® in association with Gemcitabine and Cisplatin, 90-Yttrium theraspheres | Center Eugene Marquis | Cholangiocarcinoma | 12/16 | 11/17 | | |
NCT00493883: Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors |
|
|
| Completed | 1/2 | 81 | US | yttrium Y 90 microspheres (TheraSphere®) | Southwestern Regional Medical Center | Carcinoma, Hepatocellular, Liver Neoplasms | 12/11 | 12/11 | | |
